Plasma-soluble CD30 in childhood tuberculosis: Effects of disease severity, nutritional status, and vitamin A therapy

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 2, 1999, Pages 204-208

  Hanekom, W A ^a,c   Hussey, G D ^b   Hughes, E J ^b   Potgieter, S ^b   Yogev, R ^a   Check, I J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CYTOKINE; PLACEBO; RETINOL; VITAMIN;

ANTIGEN DETECTION; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; KWASHIORKOR; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TERRAE; NUTRITIONAL STATUS; PRIORITY JOURNAL; TUBERCULOSIS; VITAMIN INTAKE;

EID: 0032978219     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.2.204-208.1999     Document Type: Article

References (24)

1. Barbes, P. F., and W. N. Rom. 1996. Cytokine production in tuberculosis, p. 291-303. In W. N. Rom and S. M. Garay (ed.), Tuberculosis. Little, Brown and Company, Boston, Mass.
2. Bowen, M. A., R. K. Lee, G. Miragliotta, S. Y. Nam, and E. R. Podack. 1996. Structure and expression of murine CD30 and its role in cytokine production. J. Immunol. 156:442-449.
3. Chilosi, M., F. Facchetti, L. D. Notarangelo, S. Romagnani, G. Del Prete, F. Almerigogna, M. De Carli, and G. Pizzolo. 1996. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition. Eur. J. Immunol. 26:329-334.
4. De Bruin, P. C., H. J. Gruss, P. Van Der Valk, R. Willemze, and C. J. Meijer. 1995. CD30 expression in normal and neoplastic lymphoid tissue: biological aspects and clinical implications. Leukemia 9:1620-1627.
5. Del Prete, G., M. De Carli, F. Almerigogna, C. K. Daniel, M. M. D'Elios, G. Zancuoghi, F. Vinante, G. Pizzolo, and S. Romagnani. 1995. Preferential expression of CD30 by human CD4+ T cells producing Th2-like cytokines. FASEB J. 9:81-86.
6. Enarson, D. A., and J. F. Murray. 1996. Global epidemiology of tuberculosis, p. 57-75. In W. N. Rom and S. M. Garay (ed.), Tuberculosis. Little, Brown and Company, Boston, Mass.
7. Falini, B., S. Pileri, G. Pizzolo, H. Durkop, L. Flenghi, F. Stirpe, M. F. Martelli, and H. Stein. 1995. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy, Blood 85:1-14.
8. Fattovich, G., F. Vinante, G. Giustina, L. Morosato, A. Alberti, A. Ruol, and G. Pizzolo. 1995. Serum levels of soluble CD30 in chronic hepatitis B virus infection. Clin. Exp. Immunol. 103:105-110.
9. + T cell involvement in the inflamed joints. Clin. Exp. Immunol. 102:547-550.
10. Gruss, H. J., and S. K. Dower. 1995. Tumor necrosis factor ligand super-family: involvement in the pathology of malignant lymphomas. Blood 85: 3378-3404.
11. Hamann, D., C. M. U. Hilkens, J. L. Grogan, S. M. A. Lens, M. L. Kapsenberg, M. Yasdanbankhsh, and R. A. W. Van Lier. 1996. CD30 expression does not discriminate between human Th1- and Th2-type T cells. J. Immunol. 156:1387-1391.
12. Hanekom, W. A., S. Potgieter, E. J. Hughes, H. Malan, G. Kessow, and G. D. Hussey. 1997. Vitamin A status and therapy in childhood tuberculosis. J. Pediatr. 131:925-927.
13. Hussey, G. D., and M. Klein. 1990. A randomized, controlled trial of vitamin A in children with severe measles. N. Engl. J. Med. 323:160-164.
14. Kochi, A. 1991. The global tuberculosis situation and the new control strategy of the World Health Organisation. Tubercle 72:1-6.
15. + T cells by IL-4 and IFN-γ. J. Immunol. 158:2090-2098.
16. Pizzolo, G., F. Vinante, L. Morosato, G. Nadali, M. Chilosi, G. Gandini, A. Sinicco, R. Raiteri, G. Semenzato, H. Stein, and G. Perona. 1994. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 8:741-745.
17. Reiner, S. L., and R. M. Locklley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
18. Romagnani, S., G. Del Prete, E. Maggi, M. Chilosi, F. Caligaris-Cappio, and G. Pizzolo. 1995. CD30 and type 2 T helper (Th2) responses. J. Leukoc. Biol. 57:726-730.
19. Sanchez, F. O., J. I. Rodriguez, G. Agudelo, and L. F. Garcia. 1994. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect. Immun. 62:5673-5678.
20. Semba, R. D. 1994. Vitamin A. immunity and infection. Clin. Infect. Dis. 14:489-499.
21. Sieling, P. A., and R. L. Modlin, 1994. Regulation of cytokine patterns in leprosy. Ann. N. Y. Acad. Sci. 730:42-52.
22. Surcel, H. M., M. Troye-Blomberg, S. Paulie, G. Andersson, C. Moreno, G. Pasvol, and J. Ivanyi. 1994. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 81:171-176.
23. World Health Organization. WHO tuberculosis programme framework for effective tuberculosis control, p. 179. WHO/TB/94. World Health Organization, Geneva, Switzerland.
24. Zhang, M., Y. Lin, D. V. Iyer, J. Gong, J. S. Abrams, and P. F. Barnes. 1995 T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63:3231-3234.